original ) (raw )The influence of dispersive interactions on the binding affinities of ligands with an arylpiperazine moiety to the dopamine D2 receptor
Goran Roglic
Journal of The Serbian Chemical Society, 2009
View PDFchevron_right
In Silico Study of Metoclopramide as A Small Molecule of Dopamine D2 Receptor: a Quantum-Mechanical (QM) Based Molecular Docking Treatment
hamideh sabahnoo
Chemical Methodologies, 2020
View PDFchevron_right
Azaindole derivatives with high affinity for the dopamine D4 receptor: Synthesis, ligand binding studies and comparison of molecular electrostatic potential maps
Harald Hübner
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
A theoretical study to investigate D2DAR/D4DAR selectivity: receptor modeling and molecular docking of dopaminergic ligands
Tiziano Tuccinardi
Journal of medicinal …, 2006
View PDFchevron_right
Synthesis, dopamine D 2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1 H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1 H-benzimidazole and their analogs
Goran Roglic
European Journal of Medicinal Chemistry, 2005
View PDFchevron_right
The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics
Ben Capuano
Journal of molecular modeling, 2016
View PDFchevron_right
Modeling key interactions between dopamine D2 receptor second extracellular loop and arylpiperazine ligands
Vukic Soskic
Journal of the Serbian Chemical Society, 2012
View PDFchevron_right
Homology Modeling of the Dopamine D2 Receptor and Its Testing by Docking of Agonists and Tricyclic Antagonists
Curtiss Durand , Mark Froimowitz
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Ligand discovery from a dopamine D3 receptor homology model and crystal structure
John Irwin
Nature Chemical Biology, 2011
View PDFchevron_right
Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation
Salvatore Salomone
PLoS ONE, 2012
View PDFchevron_right
Investigation of key interactions between the second extracellular loop of dopamine D2 receptor and several hydroxy-N-{[2-(4-phenyl-piperaziny-1-yl)ethyl]phenyl}-nicotinamides
Đurđica Ignjatović
Journal of the Serbian Chemical Society, 2014
View PDFchevron_right
Molecular electrostatic potential of D1 and D2 dopamine agonists
Hugo Villar
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives
Rajendra Nath
Bioinformation, 2014
View PDFchevron_right
Modeling of ligand binding to dopamine D2 receptor
Ramona Rad
Journal of the Serbian Chemical Society, 2014
View PDFchevron_right
Bivalent molecular probes for dopamine D2-like receptors
Harald Hübner
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right
Synthesis, in silico, and in vitro studies of novel dopamine D 2 and D 3 receptor ligands
Holger Stark
Archiv der Pharmazie, 2021
View PDFchevron_right
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
Katarina Nikolic
Archiv Der Pharmazie, 2021
View PDFchevron_right
Conformational Analysis of D1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping
Val Watts
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions
Ramin Ekhteiari Salmas
Molecular Diversity, 2015
View PDFchevron_right
N-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as Selective Dopamine D3 Receptor Ligands: Critical Role of the Carboxamide Linker for D3 Receptor Selectivity
Yogesh Mishra
Journal of Medicinal Chemistry, 2011
View PDFchevron_right
3-Chlorotyramine Acting as Ligand of the D2Dopamine Receptor. Molecular Modeling, Synthesis and D2Receptor Affinity
Margarita Villecco
Molecular Informatics, 2014
View PDFchevron_right
Computational Elucidation of the Structural Basis of Ligand Binding to the Dopamine 3 Receptor through Docking and Homology Modeling
Ganesh Sahoo
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Molecular dynamics of dopamine at the D2 receptor
Ingebrigt Sylte
Proceedings of the National Academy of Sciences, 1991
View PDFchevron_right
Studies of the Active Conformation of a Novel Series of Benzamide Dopamine D2 Agonists
David Wustrow
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Three amino acids in the D 2 dopamine receptor regulate selective ligand function and affinity
Spencer S Ericksen
Journal of Neurochemistry, 2009
View PDFchevron_right
Comparative Molecular Field Analysis of Dopamine D4 Receptor Antagonists Including 3-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5- a ]pyridine (FAUC 113), 3-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]-1 H -pyrrolo[2,3- b ]pyridine (L-745,870), and Clozapine
Peter Gmeiner
Journal of Medicinal Chemistry, 2001
View PDFchevron_right
Probing the Steric Space at the Floor of the D1 Dopamine Receptor Orthosteric Binding Domain: 7α-, 7β-, 8α-, and 8β-Methyl Substituted Dihydrexidine Analogues
Val Watts
Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Probing the Steric Space at the Floor of the D1 Dopamine Receptor Orthosteric Binding Domain: 7α-, 7β-, 8α-, and 8β-Methyl Substituted Dihydrexidine Analogues
David Nichols
Journal of Medicinal Chemistry, 2011
View PDFchevron_right